Detection Of Drugs Of Abuse In Alternative Biological Fluids And Tissues
检测替代生物液体和组织中的滥用药物
基本信息
- 批准号:8336426
- 负责人:
- 金额:$ 40.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:BehaviorBiologicalBloodBody FluidsCannabinoidsChemicalsChemistryClinical ResearchCocaineCriminal JusticeDatabasesDependencyDetectionDevelopmentDiagnosisDisadvantagedDoseDrug ExposureDrug KineticsDrug MonitoringDrug abuseDrug usageExcretory functionGoalsHairIndividualLiquid substanceMeasuresMetabolicMethamphetamineMethodsMilitary PersonnelMonitorNail plateNicotineOpiatesOralPain managementParentsPatternPerformancePharmaceutical PreparationsPharmacodynamicsPhysiologicalPlasmaPrevalence StudyProceduresPropertyRecording of previous eventsResearchSebumSeriesSkinSpecimenSubstance abuse problemSweatSweat testSweatingTechnologyTestingTimeTissuesUmbilical Cord BloodUrineWorkplacedesigndriving under influencedrug metabolismdrug of abusedrug testinghuman subjectimprovedprograms
项目摘要
Drug testing of biological specimens such as urine, oral fluid, sweat and hair provides an objective means of diagnosing drug use and monitoring subjects in treatment. Traditionally, urine testing has been used, but this technology has limitations. In a series of ongoing studies, a variety of alternative biological fluids and tissues are evaluated for usefulness in monitoring individual patterns of substance abuse. Clinical studies were designed to determine the identity, concentration, time course, dose dependency and variability of drug and metabolite excretion in urine, plasma, oral fluid, sweat, skin, sebum, nails, cord blood, and hair following administration of single and multiple doses of drugs of abuse to human subjects. Each biological specimen appears to be unique and offers a somewhat different pattern of information regarding drug use over time. For example, hair testing offers the possibility of detecting drug use that could have occurred within a period of several months and could be useful in monitoring individuals in long-term treatment and in prevalence studies. In contrast, oral fluid offers a short term measure of drug exposure that may correlate more closely with some drug concentrations in blood and with drug-induced effects. Sweat can be used for monitoring over a period of 1-2 weeks. Oral fluid, hair and sweat testing for drugs of abuse are currently under consideration for federally mandated drug testing programs, and are being employed more commonly in workplace, criminal justice, treatment and military drug testing programs. There may also be disadvantages associated with the use of a particular biological matrix. Basic pharmacological properties such as dose-concentration and concentration-time relationships are evaluated in our research. Overall, each biological matrix shows promise of revealing useful information regarding an individual's drug exposure history. Analysis of drugs in alternative matrices requires development of sensitive, selective and specific chemical methods for the detection and quantification of drugs and metabolites. Analytical procedures are continually evaluated for improving the detection and quantification of parent drug and metabolic products of cocaine, opiates, methamphetamine, cannabinoids and nicotine in blood, plasma, sweat, oral fluid, urine, skin, sebum and hair.
对尿液、口腔液、汗液和头发等生物样本进行药物检测提供了诊断药物使用和监测治疗对象的客观手段。传统上,人们使用尿液检测,但该技术有局限性。在一系列正在进行的研究中,评估了各种替代生物液体和组织在监测个体药物滥用模式方面的有用性。临床研究旨在确定单次和多次给药后尿液、血浆、口腔液、汗液、皮肤、皮脂、指甲、脐带血和头发中药物和代谢物排泄的特性、浓度、时程、剂量依赖性和变异性。人类受试者滥用药物的剂量。每个生物样本似乎都是独一无二的,并且随着时间的推移提供了一些不同模式的有关药物使用的信息。例如,头发测试提供了检测几个月内可能发生的药物使用的可能性,并且可用于监测长期治疗和患病率研究中的个体。相比之下,口腔液提供了药物暴露的短期测量方法,可能与血液中的某些药物浓度以及药物引起的作用更密切相关。汗液可用于监测 1-2 周。 目前正在考虑将口腔液、头发和汗液检测滥用药物纳入联邦强制药物检测项目,并且在工作场所、刑事司法、治疗和军事药物检测项目中更广泛地采用。还可能存在与使用特定生物基质相关的缺点。我们的研究评估了剂量-浓度和浓度-时间关系等基本药理学特性。总体而言,每种生物基质都有望揭示有关个人药物暴露史的有用信息。对替代基质中的药物进行分析需要开发灵敏、选择性和特异性的化学方法来检测和定量药物和代谢物。不断评估分析程序,以改进血液、血浆、汗液、口腔液、尿液、皮肤、皮脂和头发中可卡因、阿片剂、甲基苯丙胺、大麻素和尼古丁的母体药物和代谢产物的检测和定量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARILYN A HUESTIS其他文献
MARILYN A HUESTIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARILYN A HUESTIS', 18)}}的其他基金
Pharmacokinetics And Pharmacodynamics Of Drugs Of Abuse
滥用药物的药代动力学和药效学
- 批准号:
8336428 - 财政年份:
- 资助金额:
$ 40.7万 - 项目类别:
Neurobiology and Pharmacokinetics of Acute MDMA Administration
急性 MDMA 给药的神经生物学和药代动力学
- 批准号:
7593277 - 财政年份:
- 资助金额:
$ 40.7万 - 项目类别:
Detection Of Drugs Of Abuse In Alternative Biological Fluids And Tissues
检测替代生物液体和组织中的滥用药物
- 批准号:
8148502 - 财政年份:
- 资助金额:
$ 40.7万 - 项目类别:
Pharmacokinetics And Pharmacodynamics Of Smoked Drugs Of Abuse
滥用吸食药物的药代动力学和药效学
- 批准号:
8148503 - 财政年份:
- 资助金额:
$ 40.7万 - 项目类别:
Pharmacokinetics And Pharmacodynamics Of Smoked Drugs Of Abuse
滥用吸食药物的药代动力学和药效学
- 批准号:
8933807 - 财政年份:
- 资助金额:
$ 40.7万 - 项目类别:
Neurobiology/Pharmacokinetics-Acute MDMA Administration
神经生物学/药代动力学 - 急性 MDMA 给药
- 批准号:
7149323 - 财政年份:
- 资助金额:
$ 40.7万 - 项目类别:
Neurobiology and Pharmacokinetics of Acute MDMA Administration
急性 MDMA 给药的神经生物学和药代动力学
- 批准号:
7966817 - 财政年份:
- 资助金额:
$ 40.7万 - 项目类别:
Development Of New Pharmacologic And Biologic Treatments For Drug Dependence
药物依赖性新药物和生物治疗的开发
- 批准号:
8336422 - 财政年份:
- 资助金额:
$ 40.7万 - 项目类别:
Pharmacokinetics And Pharmacodynamics Of Smoked Drugs Of Abuse
滥用吸食药物的药代动力学和药效学
- 批准号:
8336427 - 财政年份:
- 资助金额:
$ 40.7万 - 项目类别:
相似国自然基金
岩藻糖化硫酸软骨素寡糖衍生物对血小板介导肿瘤血行转移的抑制作用机制研究
- 批准号:82304374
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
龙血酮衍生物的优化合成及其基于Keap1-NQO1通路的肝癌化学预防作用
- 批准号:22307008
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
- 批准号:82305216
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MYC2介导乙烯利促进低温贮藏血橙花色苷生物合成的作用机制
- 批准号:32360602
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
脉络膜黑色素瘤循环血内肿瘤细胞的捕获、扩增、生物学特征分析与外泌体载药模型构建的研究
- 批准号:82303540
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
An Integrated Model of Contextual Safety, Social Safety, and Social Vigilance as Psychosocial Contributors to Cardiovascular Disease
情境安全、社会安全和社会警惕作为心血管疾病社会心理因素的综合模型
- 批准号:
10749134 - 财政年份:2024
- 资助金额:
$ 40.7万 - 项目类别:
Potential of tissue kallikreins as therapeutic targets for neuropsychiatric lupus
组织激肽释放酶作为神经精神狼疮治疗靶点的潜力
- 批准号:
10667764 - 财政年份:2023
- 资助金额:
$ 40.7万 - 项目类别:
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in at-risk Older Adults
同时进行有氧运动和认知训练可预防高危老年人的阿尔茨海默病
- 批准号:
10696409 - 财政年份:2023
- 资助金额:
$ 40.7万 - 项目类别:
Role of neuronal hemoglobin in chronic stress-induced mitochondrial adaptation in hippocampal PV interneurons
神经元血红蛋白在海马PV中间神经元慢性应激诱导的线粒体适应中的作用
- 批准号:
10667084 - 财政年份:2023
- 资助金额:
$ 40.7万 - 项目类别:
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
- 批准号:
10666307 - 财政年份:2023
- 资助金额:
$ 40.7万 - 项目类别: